Seascape Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5M | Sell |
26,924
-149
| -0.6% | -$27.7K | 1.58% | 21 |
|
2025
Q1 | $5.67M | Sell |
27,073
-471
| -2% | -$98.7K | 1.98% | 9 |
|
2024
Q4 | $4.9M | Buy |
27,544
+433
| +2% | +$77K | 1.7% | 18 |
|
2024
Q3 | $5.35M | Sell |
27,111
-665
| -2% | -$131K | 1.91% | 12 |
|
2024
Q2 | $4.76M | Buy |
27,776
+356
| +1% | +$61.1K | 1.78% | 15 |
|
2024
Q1 | $4.99M | Sell |
27,420
-628
| -2% | -$114K | 1.86% | 12 |
|
2023
Q4 | $4.35M | Buy |
28,048
+628
| +2% | +$97.3K | 1.83% | 11 |
|
2023
Q3 | $4.09M | Buy |
27,420
+154
| +0.6% | +$23K | 1.94% | 10 |
|
2023
Q2 | $3.67M | Sell |
27,266
-203
| -0.7% | -$27.4K | 1.74% | 11 |
|
2023
Q1 | $4.38M | Sell |
27,469
-2,392
| -8% | -$381K | 2.23% | 8 |
|
2022
Q4 | $4.83M | Sell |
29,861
-572
| -2% | -$92.4K | 2.63% | 5 |
|
2022
Q3 | $4.08M | Buy |
30,433
+1,786
| +6% | +$240K | 2.8% | 5 |
|
2022
Q2 | $4.39M | Buy |
28,647
+79
| +0.3% | +$12.1K | 2.66% | 6 |
|
2022
Q1 | $4.63M | Sell |
28,568
-305
| -1% | -$49.4K | 2.4% | 7 |
|
2021
Q4 | $3.91M | Buy |
28,873
+679
| +2% | +$91.9K | 1.83% | 14 |
|
2021
Q3 | $3.04M | Buy |
28,194
+2,210
| +9% | +$238K | 1.56% | 23 |
|
2021
Q2 | $2.93M | Buy |
25,984
+404
| +2% | +$45.5K | 1.52% | 18 |
|
2021
Q1 | $2.77M | Buy |
25,580
+22
| +0.1% | +$2.38K | 1.54% | 17 |
|
2020
Q4 | $2.74M | Buy |
25,558
+1,223
| +5% | +$131K | 1.6% | 14 |
|
2020
Q3 | $2.13M | Sell |
24,335
-87
| -0.4% | -$7.62K | 1.35% | 21 |
|
2020
Q2 | $2.4M | Sell |
24,422
-1,650
| -6% | -$162K | 1.72% | 11 |
|
2020
Q1 | $1.99M | Buy |
26,072
+319
| +1% | +$24.3K | 1.8% | 12 |
|
2019
Q4 | $2.28M | Buy |
+25,753
| New | +$2.28M | 1.63% | 22 |
|